The latter is a highly surprising finding, because it suggests that in DMD additional dystrophin-independent mechanisms may be contributing to muscle fiber detachment, which can be ameliorated by increasing atrogin-1 levels, thus providing alternative therapeutic approaches for DMD. This evidence concerns the gene FBXO32 and Duchenne muscular dystrophy.